Clinical Trials Directory

Trials / Completed

CompletedNCT01297166

A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris

A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
25 (actual)
Sponsor
LEO Pharma · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the anti-psoriatic effect of LEO 27989 ointment and calcipotriol plus LEO 27989 ointment, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.

Conditions

Interventions

TypeNameDescription
DRUGLEO 27989 ointmentonce daily application, 3weeks
DRUGCalcipotriol plus LEO 27989 ointmentonce daily application, 3weeks
DRUGCalcipotriol ointmentonce daily application, 3weeks
DRUGVehicle ointmentonce daily application, 3weeks

Timeline

Start date
2011-02-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-02-16
Last updated
2025-02-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01297166. Inclusion in this directory is not an endorsement.